Back to Journals » OncoTargets and Therapy » Volume 15 » default

OncoTargets and Therapy

ISSN: 1178-6930


Archive: Volume 15, 2022

Overexpression of BCL2, BCL6, VEGFR1 and TWIST1 in Circulating Tumor Cells Derived from Patients with DLBCL Decreases Event-Free Survival

Cerón R, Martínez A, Ramos C, De la Cruz A, García A, Mendoza I, Palmeros G, Montaño Figueroa EH, Navarrete J, Jiménez-Morales S, Martinez-Murillo C, Olarte I

OncoTargets and Therapy 2022, 15:1583-1595

Published Date: 30 December 2022

Combination Use of First-Line Afatinib and Proton-Pump Inhibitors Reduces Overall Survival Among Patients with EGFFR Mutant Lung Cancer

Ho MC, Chung YS, Lin YC, Hung MS, Fang YH

OncoTargets and Therapy 2022, 15:1573-1582

Published Date: 28 December 2022

Spotlight on Targeted Chemotherapy in Retinoblastoma: Safety, Efficacy, and Patient Outcomes

Naseripour M, Mirshahi R, Kasraei H, Sedaghat A, Azimi F

OncoTargets and Therapy 2022, 15:1545-1561

Published Date: 22 December 2022

Response to Article “Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages” [Response to Letter]

Reyes-Vallejo T, Conde-Rodríguez I, Serna-Villalobos J, Ramírez-Díaz I, Pérez-Villalobos G, Delgado-López G, Vázquez-Zamora VJ, Gutierrez-Quiroz CT, Ávila-Jiménez L, García-Carrancá A, Martínez-Acosta L, Santos-López G, Reyes-Leyva J, Vallejo-Ruiz V

OncoTargets and Therapy 2022, 15:1543-1544

Published Date: 22 December 2022

Targeted Therapy for Locally Advanced or Metastatic Urothelial Cancer (mUC): Therapeutic Potential of Sacituzumab Govitecan

Fontes MS, Vargas Pivato de Almeida D, Cavalin C, Tagawa ST

OncoTargets and Therapy 2022, 15:1531-1542

Published Date: 21 December 2022

Targeted Treatment of Locally Advanced and Metastatic Urothelial Cancer: Enfortumab Vedotin in Context

Hoffman-Censits J, Maldonado L

OncoTargets and Therapy 2022, 15:1519-1529

Published Date: 15 December 2022

Chemotherapy Induces Ovarian Cancer Cell Repopulation Through the Caspase 3-Mediated Arachidonic Acid Metabolic Pathway [Corrigendum]

Cui LZ, Zhao YW, Pan Y, Zheng X, Shao D, Jia Y, He K, Li K, Chen L

OncoTargets and Therapy 2022, 15:1503-1504

Published Date: 5 December 2022

Diffuse Large B-Cell Lymphoma (DLBCL): Early Patient Management and Emerging Treatment Options

Vodicka P, Klener P, Trneny M

OncoTargets and Therapy 2022, 15:1481-1501

Published Date: 6 December 2022

Licorice (Glycyrrhiza glabra L.)-Derived Phytochemicals Target Multiple Signaling Pathways to Confer Oncopreventive and Oncotherapeutic Effects

Tuli HS, Garg VK, Mehta JK, Kaur G, Mohapatra RK, Dhama K, Sak K, Kumar A, Varol M, Aggarwal D, Anand U, Kaur J, Gillan R, Sethi G, Bishayee A

OncoTargets and Therapy 2022, 15:1419-1448

Published Date: 30 November 2022

Successful Targeting of CTLA-4 in a Melanoma Clinical Case: A Long-Term “One Stop Therapeutic Shop”

Colucci M, D'Alonzo V, Santangelo F, Miracco C, Valente M, Maio M, Di Giacomo AM

OncoTargets and Therapy 2022, 15:1409-1415

Published Date: 25 November 2022

miR-96-5p Suppresses the Progression of Nasopharyngeal Carcinoma by Targeting CDK1 [Retraction]

Luo X, He X, Liu X, Zhong L, Hu W

OncoTargets and Therapy 2022, 15:1407-1408

Published Date: 22 November 2022

HIF1 α/PD-L1 Axis Mediates Hypoxia-Induced Cell Apoptosis and Tumor Progression in Follicular Thyroid Carcinoma [Retraction]

Zhou L, Cha G, Chen L, Yang C, Xu D, Ge M

OncoTargets and Therapy 2022, 15:1403-1404

Published Date: 21 November 2022

MicroRNA-211 Promotes Non-Small-Cell Lung Cancer Proliferation and Invasion by Targeting MxA [Retraction]

Kang M, Shi J, Peng N, He S

OncoTargets and Therapy 2022, 15:1387-1388

Published Date: 16 November 2022

7β-22 Dihydroxyhopane, Isolated from the Sub-Antarctic Lichen, Inhibits the Viability and Stemness in Glioma Stem Like Cells

Kim HJ, Suh SS, Park J, Shin MJ, Koo MH, Lee SJ, Jeon YJ, Lee S, Youn UJ, Kim SH

OncoTargets and Therapy 2022, 15:1375-1383

Published Date: 15 November 2022

Promising Response to Dabrafenib Plus Trametinib in a Patient with Peritoneal Carcinomatosis from Non Small Lung Cancer Harboring BRAF V600E Mutation

Yagami Y, Nakahara Y, Manabe H, Yamamoto H, Otani S, Sato T, Igawa S, Kubota M, Sasaki J, Naoki K

OncoTargets and Therapy 2022, 15:1369-1374

Published Date: 11 November 2022

Aberrant MAPK Signaling Offers Therapeutic Potential for Treatment of Ovarian Carcinoma

Colic E, Patel PU, Kent OA

OncoTargets and Therapy 2022, 15:1331-1346

Published Date: 5 November 2022

The Eosinophil Changes, Efficacy and Safety of Pembrolizumab in Advanced Urothelial Carcinoma Patients with an Older Age and a Poor Performance Status

Furubayashi N, Minato A, Negishi T, Sakamoto N, Song Y, Hori Y, Tomoda T, Harada M, Tamura S, Kobayashi H, Wada Y, Kuroiwa K, Seki N, Fujimoto N, Nakamura M

OncoTargets and Therapy 2022, 15:1321-1330

Published Date: 5 November 2022

Hopea odorata Extract Inhibits Hepatocellular Carcinoma via Induction of Caspase-Dependent Apoptosis [Erratum]

Nguyen ST, Huynh KL, Nguyen HL, Nguyen Thi Thanh M, Nguyen Trung N, Nguyen Xuan H, Ngoc KP, Truong Dinh K, Pham PV

OncoTargets and Therapy 2022, 15:1319-1320

Published Date: 1 November 2022

In vitro Characterization of Enhanced Human Immune Responses by GM-CSF Encoding HSV-1-Induced Melanoma Cells

Delic M, Boeswald V, Goepfert K, Pabst P, Moehler M

OncoTargets and Therapy 2022, 15:1291-1307

Published Date: 27 October 2022

Snake Venom Causes Apoptosis by Increasing the Reactive Oxygen Species in Colorectal and Breast Cancer Cell Lines [Corrigendum]

Al-Asmari AK, Riyasdeen A, Al-Shahrani MH, Islam M

OncoTargets and Therapy 2022, 15:1289-1290

Published Date: 26 October 2022

A Case of Hepatocellular Carcinoma Successfully Resumed Atezolizumab and Bevacizumab After Associated Grade 3 Diarrhea and Grade 2 Colitis: Case Report and Literature Review

Fuji T, Arai J, Otoyama Y, Nio Y, Sugiura I, Nakajima Y, Kajiwara A, Ichikawa Y, Uozumi S, Shimozuma Y, Uchikoshi M, Sakaki M, Nozawa H, Momo K, Sasaki T, Yoshida H

OncoTargets and Therapy 2022, 15:1281-1288

Published Date: 25 October 2022

PAX8 as a Potential Target for Ovarian Cancer: What We Know so Far

Di Palma T, Zannini M

OncoTargets and Therapy 2022, 15:1273-1280

Published Date: 21 October 2022

Immunotherapy for Urothelial Carcinoma: Focus on Clinical Utility of Nivolumab

Chiang RS, Glover MJ, Khaki AR, Srinivas S

OncoTargets and Therapy 2022, 15:1259-1269

Published Date: 20 October 2022

Exosomal Tenascin-c Induces Proliferation and Invasion of Pancreatic Cancer Cells by WNT Signaling [Retraction]

Qian S, Tan X, Liu X, Liu P, Wu Y

OncoTargets and Therapy 2022, 15:1257-1258

Published Date: 20 October 2022

CCNB1 Expedites the Progression of Cervical Squamous Cell Carcinoma via the Regulation by FOXM1 [Retraction]

Li S, Liu N, Piao J, Meng F, Li Y

OncoTargets and Therapy 2022, 15:1255-1256

Published Date: 20 October 2022

Spermidine Promotes Nb CAR-T Mediated Cytotoxicity to Lymphoma Cells Through Elevating Proliferation and Memory

Wang H, Jiang D, Liu L, Zhang Y, Qin M, Qu Y, Wang L, Wu S, Zhou H, Xu T, Xu G

OncoTargets and Therapy 2022, 15:1229-1243

Published Date: 18 October 2022

Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages

Reyes-Vallejo T, Conde-Rodríguez I, Serna-Villalobos J, Ramírez-Díaz I, Pérez-Villalobos G, Delgado-López G, Vazquez-Zamora VJ, Gutiérrez-Quiroz CT, Ávila-Jiménez L, García-Carrancá A, Martínez-Acosta L, Santos-López G, Reyes-Leyva J, Vallejo-Ruiz V

OncoTargets and Therapy 2022, 15:1211-1220

Published Date: 13 October 2022

Targeting FGFR2 Positive Gastroesophageal Cancer: Current and Clinical Developments

Gordon A, Johnston E, Lau DK, Starling N

OncoTargets and Therapy 2022, 15:1183-1196

Published Date: 11 October 2022

Upregulated Ubiquitin D is a Favorable Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative Concurrent Chemoradiotherapy

Chou CL, Chen TJ, Li WS, Lee SW, Yang CC, Tian YF, Lin CY, He HL, Wu HC, Shiue YL, Li CF, Kuo YH

OncoTargets and Therapy 2022, 15:1171-1181

Published Date: 11 October 2022

Survivin Splice Variant 2β Enhances Pancreatic Ductal Adenocarcinoma Resistance to Gemcitabine

Fuller RN, Kabagwira J, Vallejos PA, Folkerts AD, Wall NR

OncoTargets and Therapy 2022, 15:1147-1160

Published Date: 10 October 2022

Downregulation of CENPK Suppresses Hepatocellular Carcinoma Malignant Progression through Regulating YAP1 [Corrigendum]

Wang J, Li H, Xia C, Yang X, Dai B, Tao K, Dou K

OncoTargets and Therapy 2022, 15:1143-1145

Published Date: 10 October 2022

Molecular Changes in Chronic Myeloid Leukemia During Tyrosine Kinase Inhibitors Treatment. Focus on Immunological Pathways

Janowski M, Ulańczyk Z, Łuczkowska K, Sobuś A, Rogińska D, Pius-Sadowska E, Gniot M, Kozłowski K, Lewandowski K, Helbig G, Machaliński B, Paczkowska E

OncoTargets and Therapy 2022, 15:1123-1141

Published Date: 10 October 2022

Ovarian Cancer Therapy: Homologous Recombination Deficiency as a Predictive Biomarker of Response to PARP Inhibitors

Miller RE, Elyashiv O, El-Shakankery KH, Ledermann JA

OncoTargets and Therapy 2022, 15:1105-1117

Published Date: 4 October 2022

A Multidisciplinary Approach to the Management of Fibrolamellar Carcinoma: Current Perspectives and Future Prospects

Polychronidis G, Murtha-Lemekhova A, Fuchs J, Karathanasi E, Hoffmann K

OncoTargets and Therapy 2022, 15:1095-1103

Published Date: 3 October 2022

Efficacy and Safety of Pyrotinib in Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Multicenter, Retrospective, Real-World Study

Zhang X, Li Z, Han L, Lv Z, Teng Y, Cui X, Zhou C, Wu H, Fang W, Xu L, Zhao S, Song C, Zheng Y, Gao T, Li M

OncoTargets and Therapy 2022, 15:1067-1078

Published Date: 28 September 2022

ITGA2 Overexpression Promotes Esophageal Squamous Cell Carcinoma Aggression via FAK/AKT Signaling Pathway [Corrigendum]

Huang W, Zhu J, Shi H, Wu Q, Zhang C

OncoTargets and Therapy 2022, 15:1063-1065

Published Date: 27 September 2022

Clinical Evidence and Selecting Patients for Treatment with Erdafitinib in Advanced Urothelial Carcinoma

Sayegh N, Tripathi N, Agarwal N, Swami U

OncoTargets and Therapy 2022, 15:1047-1055

Published Date: 25 September 2022

Effects of Combined Inhibition of STAT3 and VEGFR2 Pathways on the Radiosensitivity of Non-Small-Cell Lung Cancer Cells [Retraction]

Hu C, Zhuang W, Qiao Y, Liu B, Liu L, Hui K, Jiang X

OncoTargets and Therapy 2022, 15:1045-1046

Published Date: 23 September 2022

Down-Regulation of SREBP via PI3K/AKT/mTOR Pathway Inhibits the Proliferation and Invasion of Non-Small-Cell Lung Cancer Cells [Retraction]

Zhang B, Wu J, Guo P, Wang Y, Fang Z, Tian J, Yu Y, Teng W, Luo Y, Li Y

OncoTargets and Therapy 2022, 15:1039-1040

Published Date: 23 September 2022

A Unique Three-Way Variant Philadelphia Chromosome t(6;9;22)(p21.3;q34;q11.2) in a Newly Diagnosed Patient with Chronic Myeloid Leukemia Responded to Flumatinib

Chen L, Zhang J, Yang N, Tan N, Meng D, Zhang F, Qi Y, Wu G, Li Z

OncoTargets and Therapy 2022, 15:1033-1037

Published Date: 20 September 2022

Molecular Characteristics and the Effect of KRAS Mutation on the Prognosis of Immunotherapy in Non-Small Cell Lung Cancer in Xinjiang, China

Gu G, Yu B, Wan H, Lu S, Zhu X, Zhao Y, Fuxi Y, Liu C

OncoTargets and Therapy 2022, 15:1021-1032

Published Date: 21 September 2022

PTEN Expression Was Significantly Associated with PD-L1 Score but Not with EBV Infection in Gastric Cancer

Cao D, Su T, Wu Y, Jia Z, Fu Y, Sun Y, Jin M, Wang Y, Yi J, Cui Y, Zhang Y, Lv H, Qu L, Jiang J, Cao X

OncoTargets and Therapy 2022, 15:1011-1020

Published Date: 21 September 2022

Circular RNA Controls Tumor Occurrence and Development via Cell Cycle Regulation

Liu F, Qu R, Yang L, Shi G, Hao S, Hu C

OncoTargets and Therapy 2022, 15:993-1009

Published Date: 15 September 2022

Long-Term Treatment-Free Survival After Multimodal Therapy in a Patient with Stage IV Lung Adenocarcinoma

Takaoka H, Terai H, Emoto K, Shigematsu L, Ito F, Saito A, Okada M, Ohgino K, Ikemura S, Yasuda H, Nakachi I, Kawada I, Fukunaga K, Soejima K

OncoTargets and Therapy 2022, 15:981-989

Published Date: 14 September 2022

Case Report and Review of Literature: Camrelizumab Combined with Fuzuloparib and Apatinib for Platinum-Resistant Recurrent Ovarian Cancer

Wu Y, Zhang X, Li L, Yang W, Yan Z, Gu C, Zhang Z, Zhou J, Liu L, Ye M, Meng Y

OncoTargets and Therapy 2022, 15:973-979

Published Date: 12 September 2022

Role of the JNK Pathway in Bladder Cancer

Lee EH, Kim HT, Chun SY, Chung JW, Choi SH, Lee JN, Kim BS, Yoo ES, Kwon TG, Kim TH, Ha YS

OncoTargets and Therapy 2022, 15:963-971

Published Date: 5 September 2022

Leukoencephalopathy During Daratumumab-Based Therapy: A Case Series of Two Patients with Multiple Myeloma

Kareem SS, Viswanathan N, Sahebjam S, Tran ND, Gatewood T, Tobon K, Baz R, Piña Y, Shain KH, Mokhtari S

OncoTargets and Therapy 2022, 15:953-962

Published Date: 6 September 2022

Chronological Liquid Biopsy Reveals the Impact of Platinum-Based Chemotherapy on a Prostate Cancer Patient’s CDK12 Mutation: A Case Report

Zhu S, Bao Y, Zheng L, Zhao J, Chen Y, Huang R, Sun G, Zhao F, Zhang X, Liang J, Chen J, Wang Z, Ni Y, Chen N, Shen P, Zeng H

OncoTargets and Therapy 2022, 15:947-952

Published Date: 2 September 2022

Establishment of Nomogram Model for Minimally Invasive Treatment of Small Hepatocellular Carcinoma Based on CD8+T Cell Counts

Pu Q, Yu L, Wang X, Yan H, Xie Y, Du J, Yang Z

OncoTargets and Therapy 2022, 15:925-940

Published Date: 31 August 2022

Tumor Heterogeneity and Drug Resistance Mutations Using ctDNA in Metastatic EGFR Mutation-Positive Lung Adenocarcinoma: A Case Report

Sun J, Sun G, Lu K, Xu L, Qu X, Cheng Y, Pan E, Yang P, Wu T, Zhang Y, He H

OncoTargets and Therapy 2022, 15:919-923

Published Date: 30 August 2022

Ectopic Adrenocorticotropic Hormone-Secreting Pituitary Adenoma in the Clivus Region: A Case Report

Zhang Y, Wu D, Wang R, Luo M, Wang D, Wang K, Ai Y, Zheng L, Zhang Q, Shi L

OncoTargets and Therapy 2022, 15:913-918

Published Date: 29 August 2022

Overcoming Obstacles in Liquid Biopsy Developments for Prostate Cancer

Jang A, Rauterkus GP, Vaishampayan UN, Barata PC

OncoTargets and Therapy 2022, 15:897-912

Published Date: 26 August 2022

Remission from the 5-Fu-Based Chemotherapy to Gemcitabine-Based Chemotherapy-Based on the Pathological Classification of Periampullary Carcinoma: A Case Report and Literature Review

Hu W, Duan Z, Zhang Y, Liu J, Bao J, Gao R, Tang Y, Liu T, Xiong H, Li W, Fu X, Liao S, Fang L, Liang B

OncoTargets and Therapy 2022, 15:891-896

Published Date: 25 August 2022

Sequential Afatinib and Osimertinib in Asian Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer and Acquired T790M: Combined Analysis of Two Global Non-Interventional Studies

Miura S, Jung HA, Lee SY, Lee SH, Lee MK, Lee YC, Hochmair MJ, Yang CT, Märten A, Yang JCH, Popat S

OncoTargets and Therapy 2022, 15:873-882

Published Date: 22 August 2022

Immunotherapy in the Treatment of Platinum-Resistant Ovarian Cancer: Current Perspectives

Awada A, Ahmad S, McKenzie ND, Holloway RW

OncoTargets and Therapy 2022, 15:853-866

Published Date: 10 August 2022

Emodin Suppresses Proliferation, Migration and Invasion in Ovarian Cancer Cells by down Regulating ILK in vitro and in vivo [Retraction]

Lu JJ, Xu Y, Zhao Z, Ke XN, Wei X, Kang J, Zong X, Mao HL, Liu PS

OncoTargets and Therapy 2022, 15:851-852

Published Date: 10 August 2022

MicroRNA-212 Inhibits Hepatocellular Carcinoma Cell Proliferation and Induces Apoptosis by Targeting FOXA1 [Retraction]

Tu H, Wei G, Cai Q, Chen X, Sun Z, Cheng C, Zhang L, Feng Y, Zhou H, Zhou B, Zeng T

OncoTargets and Therapy 2022, 15:849-850

Published Date: 10 August 2022

Antimetastatic Effect of Epigenetic Drugs, Hydralazine and Valproic Acid, in Ras-Transformed NIH 3T3 Cells [Corrigendum]

Pérez-Cárdenas E, Taja-Chayeb L, Trejo-Becerril C, Chanona-Vilchis J, Chávez-Blanco A, Domínguez-Gómez G, Langley E, García-Carrancá A, Dueñas-González A

OncoTargets and Therapy 2022, 15:845-846

Published Date: 4 August 2022

MicroRNA-139-3p Inhibits the Growth and Metastasis of Ovarian Cancer by Inhibiting ELAVL1 [Retraction]

Xue F, Li QR, Xu YH, Zhou HB

OncoTargets and Therapy 2022, 15:839-840

Published Date: 2 August 2022

Hepatoid Adenocarcinoma of the Lung: Beyond a Shadow of Doubt and Risk of High Mortality [Letter]

Zehra SS, Jahangir Z, Batool A

OncoTargets and Therapy 2022, 15:837-838

Published Date: 2 August 2022

Forkhead Box Protein A1 is a Prognostic Predictor and Promotes Tumor Growth of Gastric Cancer [Retraction]

Ren H, Zhang P, Tang Y, Wu M, Zhang W

OncoTargets and Therapy 2022, 15:829-830

Published Date: 29 July 2022

Potassium Channels as a Target for Cancer Therapy: Current Perspectives

Zúñiga L, Cayo A, González W, Vilos C, Zúñiga R

OncoTargets and Therapy 2022, 15:783-797

Published Date: 20 July 2022

The Multifunction of miR-218-5p-Cx43 Axis in Breast Cancer [Expression of Concern]

Xia C, Jiang H, Ye F, Zhuang Z

OncoTargets and Therapy 2022, 15:781-782

Published Date: 18 July 2022

miR-152-3p Sensitizes Glioblastoma Cells Towards Cisplatin via Regulation of SOS1 [Expression of Concern]

Wang M, Wu Q, Fang M, Huang W, Zhu H

OncoTargets and Therapy 2022, 15:779-780

Published Date: 18 July 2022

Meg3 Induces EMT and Invasion of Glioma Cells via Autophagy [Retraction]

Yang Z, Bian E, Xu Y, Ji X, Tang F, Ma C, Wang H, Zhao B

OncoTargets and Therapy 2022, 15:777-778

Published Date: 14 July 2022

Case Report: Targeted Therapy with Anlotinib for a Rare Case of Spinal Cord Glioblastoma with FGFR3 Mutation

Liu R, Wei W, Hou H, Cong P, Zhou Y, Yu X

OncoTargets and Therapy 2022, 15:771-776

Published Date: 11 July 2022

Association Mining Identifies MAL2 as a Novel Tumor Suppressor in Colorectal Cancer

Wang K, Yang Y, Zheng S, Hu W

OncoTargets and Therapy 2022, 15:761-769

Published Date: 9 July 2022

Circular RNA circGSE1 Promotes Cervical Cancer Progression Through miR-138-5p/Vimentin [Retraction]

Fan S, Zhao S, Gao X, Qin Q, Guo Y, Yuan Z, Zhang M, Liu Q, Li H

OncoTargets and Therapy 2022, 15:759-760

Published Date: 12 July 2022

MicroRNA-769-5p Promotes the Growth of Glioma Cells by Targeting Lysine Methyltransferase 2A [Retraction]

Chang M, Yan P, Zhang B, Zhang G, Wang J, Ge H, Han N, Du C, Shi W, Tian Y

OncoTargets and Therapy 2022, 15:757-758

Published Date: 8 July 2022

A Case of Pneumonia Masking Pleural Malignancy

Xu Q, Tian J, Huang L, Zhong Q, Xu Y, Liu L, Shi J

OncoTargets and Therapy 2022, 15:741-746

Published Date: 2 July 2022

Upregulation of Cartilage Oligomeric Matrix Protein Predicts Poor Prognosis in Urothelial Carcinoma

Kuo YH, Lai HY, Chan TC, Hsing CH, Huang SK, Hsieh KL, Chen TJ, Li WS, Lu JC, Li CF

OncoTargets and Therapy 2022, 15:727-740

Published Date: 30 June 2022

The Coexpression and Clinical Significance of Costimulatory Molecules B7-H1, B7-H3, and B7-H4 in Human Pancreatic Cancer [Retraction]

Chen Y, Sun J, Zhao H, Zhu D, Zhi Q, Song S, Zhang L, He S, Kuang Y, Zhang Z, Li D

OncoTargets and Therapy 2022, 15:699-700

Published Date: 23 June 2022

LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis [Retraction]

Bi H, Shang Z, Jia C, Wu J, Cui B, Wang Q, Ou T

OncoTargets and Therapy 2022, 15:681-682

Published Date: 15 June 2022

Long-Term Efficacy and Safety of Anlotinib as a Monotherapy and Combined Therapy for Advanced Sarcoma

Yao W, Du X, Wang J, Wang X, Zhang P, Niu X

OncoTargets and Therapy 2022, 15:669-679

Published Date: 14 June 2022

Leptomeningeal Metastatic L858R EGFR-mutant Lung Cancer: Prompt Response to Osimertinib in the Absence of T790M-mutation and Effective Subsequent Pulsed Erlotinib

Kanbour A, Salih F, Abualainin W, Abdelrazek M, Szabados L, Al-Bozom I, Omar NE

OncoTargets and Therapy 2022, 15:659-667

Published Date: 14 June 2022

FGFR2-ERC1: A Subtype of FGFR2 Oncogenic Fusion Variant in Lung Adenocarcinoma and the Response to Anlotinib

Hong C, Wei J, Zhou T, Wang X, Cai J

OncoTargets and Therapy 2022, 15:651-657

Published Date: 10 June 2022

An Effective Hormonal Therapy for a Patient with Estrogen Receptor 1 (ESR1)-Amplified Metastatic Ovarian Cancer: A Case Report

Wang Y, Tan S, Pan E, Ma Y, Wu X, Yu Z, Jiang K

OncoTargets and Therapy 2022, 15:643-649

Published Date: 9 June 2022

Successful Treatment with Short-Term Steroid Against Severe Hepatitis Confirmed by Liver Biopsy in a Patient with Advanced Squamous-Cell Lung Cancer Receiving a Combination of Pembrolizumab, Carboplatin, and Nab-Paclitaxel: A Case Report

Hayashi A, Nakamichi S, Nakayama Y, Nagano A, Mikami E, Takano N, Tozuka T, Matsumoto M, Miyanaga A, Noro R, Terasaki Y, Kubota K, Seike M, Gemma A

OncoTargets and Therapy 2022, 15:637-642

Published Date: 7 June 2022

Primary Hepatoid Adenocarcinoma of the Lung: A Systematic Literature Review

Chen Z, Ding C, Zhang T, He Y, Jiang G

OncoTargets and Therapy 2022, 15:609-627

Published Date: 1 June 2022

EGFR Mutation Status and Subtypes Predicted by CT-Based 3D Radiomic Features in Lung Adenocarcinoma

Chen Q, Li Y, Cheng Q, Van Valkenburgh J, Sun X, Zheng C, Zhang R, Yuan R

OncoTargets and Therapy 2022, 15:597-608

Published Date: 30 May 2022

Genomic Alteration Spectrum of Non-Small Cell Lung Cancer Patients in East-China Characterized by Tumor Tissue DNA and Cell-Free DNA

Li J, Chen S, Xue H, Wang H, Huang T, Xie H, He J, Ke C, Yu Z, Ni B

OncoTargets and Therapy 2022, 15:571-584

Published Date: 19 May 2022

Protein Expression of Folate Receptor Alpha in Adenoid Cystic Carcinoma of the Head and Neck

Schnoell J, Jank BJ, Kadletz-Wanke L, Stoiber S, Gurnhofer E, Schlederer M, Heiduschka G, Kenner L

OncoTargets and Therapy 2022, 15:531-538

Published Date: 16 May 2022

RANKL/RANK Pathway Abrogates Cetuximab Sensitivity in Gastric Cancer Cells via Activation of EGFR and c-Src [Corrigendum]

Zhang X, Song Y, Song N, Zhang Y, Zhang L, Wang Y, Wang Z, Qu X, Liu Y

OncoTargets and Therapy 2022, 15:529-530

Published Date: 13 May 2022

Gastric H+/K+-ATPase Expression in Normal Laryngeal Tissue and Laryngeal Carcinoma [Corrigendum]

Bao YY, Jiang Q, Li ZW, Yu E, Zhou SH, Yao HT, Fan J, Yong WW

OncoTargets and Therapy 2022, 15:527-528

Published Date: 12 May 2022

A Hybrid Glioma Tumor Cell Lysate Immunotherapy Vaccine Demonstrates Good Clinical Efficacy in the Rat Model [Corrigendum]

Li XL, Zeng S, He HP, Zeng X, Peng LL, Chen LG

OncoTargets and Therapy 2022, 15:521-522

Published Date: 6 May 2022

TROP2 as Patient-Tailoring but Not Prognostic Biomarker for Breast Cancer

Liu X, Zhou T, Wang Y, Pei M, Wang G, Chu W, Wang Q, Du S, Wang H, Wang C

OncoTargets and Therapy 2022, 15:509-520

Published Date: 3 May 2022

The Development of Non-Invasive Diagnostic Tools in Bladder Cancer

Schulz A, Loloi J, Pina Martina L, Sankin A

OncoTargets and Therapy 2022, 15:497-507

Published Date: 2 May 2022

Identification of 1,2,4-Oxadiazoles-Based Novel EGFR Inhibitors: Molecular Dynamics Simulation-Guided Identification and in vitro ADME Studies

Unadkat V, Rohit S, Parikh P, Patel K, Sanna V, Singh S

OncoTargets and Therapy 2022, 15:479-495

Published Date: 2 May 2022

MicroRNA-423 Drug Resistance and Proliferation of Breast Cancer Cells by Targeting ZFP36 [Retraction]

Xia W, Liu Y, Du Y, Cheng T, Hu X, Li X

OncoTargets and Therapy 2022, 15:469-470

Published Date: 2 May 2022

Glioblastoma: Pitfalls and Opportunities of Immunotherapeutic Combinations

Niedbała M, Malarz K, Sharma G, Kramer-Marek G, Kaspera W

OncoTargets and Therapy 2022, 15:437-468

Published Date: 28 April 2022

Targeting TP53-Mutated Acute Myeloid Leukemia: Research and Clinical Developments

Granowicz EM, Jonas BA

OncoTargets and Therapy 2022, 15:423-436

Published Date: 21 April 2022

Migfilin: Cell Adhesion Effect and Comorbidities

Duan B, Qin Z, Gu X, Li Y

OncoTargets and Therapy 2022, 15:411-422

Published Date: 19 April 2022

Pancytopenia During Osimertinib Treatment in a Patient with EGFR-Mutated Non-Small Cell Lung Cancer

Di Marino P, Chiapperino C, Primavera FC, Martino MT, Brocco D, Carella C, Grassadonia A, Tinari N, De Tursi M

OncoTargets and Therapy 2022, 15:407-410

Published Date: 11 April 2022

Hereditary Gynecologic Cancer Syndromes – A Narrative Review

Kostov S, Watrowski R, Kornovski Y, Dzhenkov D, Slavchev S, Ivanova Y, Yordanov A

OncoTargets and Therapy 2022, 15:381-405

Published Date: 8 April 2022

Genomic Analysis of Tumors from Patients with Glioblastoma with Long-Term Response to Afatinib

Owen S, Alken S, Alshami J, Guiot MC, Kavan P, Reardon DA, Muanza T, Gibson N, Pemberton K, Solca F, Cseh A, Saran F

OncoTargets and Therapy 2022, 15:367-380

Published Date: 8 April 2022

CAR T-Cell Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Progressive Muscular Dystrophy: A Case Report

Chen L, Xu B, Liu W, Wang D, Xu J, Mao X, Xiao M, Zhou J, Xiao Y

OncoTargets and Therapy 2022, 15:361-366

Published Date: 8 April 2022

Treatment of PD-1 Inhibitor-Associated Toxic Epidermal Necrolysis: A Case Report and Brief Review

Zhao Y, Cao Y, Wang X, Qian T

OncoTargets and Therapy 2022, 15:345-351

Published Date: 8 April 2022

An Innovative Site-Specific Anti-HER2 Antibody-Drug Conjugate with High Homogeneity and Improved Therapeutic Index

Hui X, Yuan C, Cao W, Ge W, Zhang D, Dan M, Zhao Q, Liu B, Yao B

OncoTargets and Therapy 2022, 15:331-343

Published Date: 8 April 2022

Genetic Testing and Immunotherapy for Intracranial Inflammatory Myofibroblastic Tumor: A Case Report

Meng X, Zhang L, Wang Q, Chen J, Zhang C, Tao R, Wang Y

OncoTargets and Therapy 2022, 15:313-321

Published Date: 1 April 2022

CDKN3 Overcomes Bladder Cancer Cisplatin Resistance via LDHA-Dependent Glycolysis Reprogramming

Li M, Che N, Jin Y, Li J, Yang W

OncoTargets and Therapy 2022, 15:299-311

Published Date: 26 March 2022

The Research Progress of Bufalin in the Treatment of Hepatocellular Carcinoma

Jiang H, Zheng H, Xia C, Li X, Wang G, Zhao T, Cui X, Wang R, Liu Y

OncoTargets and Therapy 2022, 15:291-298

Published Date: 22 March 2022

Exploring the Role of Transglutaminase in Patients with Glioblastoma: Current Perspectives

Katt WP, Aplin C, Cerione RA

OncoTargets and Therapy 2022, 15:277-290

Published Date: 19 March 2022

Efficacy of Disitamab Vedotin in Treating HER2 2+/FISH- Gastric Cancer

Dai L, Jin X, Wang L, Wang H, Yan Z, Wang G, Liang B, Huang F, Luo Y, Chen T, Wang Q

OncoTargets and Therapy 2022, 15:267-275

Published Date: 16 March 2022

Selinexor, Bortezomib and Dexamethasone: An Effective Salvage Regimen for Heavily Pretreated Myeloma Patients

Delforge M, Raddoux J, Antonis C, Clement C, Kint N, Vanhellemont A, Bravetti J, Vandenberghe P

OncoTargets and Therapy 2022, 15:243-250

Published Date: 14 March 2022

Epigenetic Activation of lncRNA MIR155HG Mediated by Promoter Hypomethylation and SP1 is Correlated with Immune Infiltration in Glioma

Wu X, Wan Q, Wang J, Hou P, Zhang Q, Wang Q, Lu X

OncoTargets and Therapy 2022, 15:219-235

Published Date: 9 March 2022

HMGB1/RAGE Axis Mediates the Apoptosis, Invasion, Autophay, and Angiogenesis of the Renal Cell Carcinoma [Corrigendum]

Wu CZ, Zheng JJ, Bai YH, Xia P, Zhang HC, Guo Y

OncoTargets and Therapy 2022, 15:217-218

Published Date: 9 March 2022

miR-132 Can Inhibit Glioma Cells Invasion and Migration by Target MMP16 in vitro [Retraction]

Wang H, Li X, Wu C, Wu Z, Li Y, Yang T, Chen G, Xie X, Huang Y, Du Z, Zhou YX

OncoTargets and Therapy 2022, 15:215-216

Published Date: 4 March 2022

Airway Fusobacterium is Associated with Poor Response to Immunotherapy in Lung Cancer

Chu S, Cheng Z, Yin Z, Xu J, Wu F, Jin Y, Yang G

OncoTargets and Therapy 2022, 15:201-213

Published Date: 28 February 2022

Expression and Prognostic Value of Glucose Transporter 3 in Diffuse Large B Cell Lymphoma

Xu Y, Zhou X, Zhang S, Nanding A, Xuan Q

OncoTargets and Therapy 2022, 15:181-191

Published Date: 25 February 2022

PARP Inhibitor Applicability: Detailed Assays for Homologous Recombination Repair Pathway Components

O'Sullivan Coyne G, Karlovich C, Wilsker D, Voth AR, Parchment RE, Chen AP, Doroshow JH

OncoTargets and Therapy 2022, 15:165-180

Published Date: 24 February 2022

Rapid and Efficient Response to Gilteritinib and Venetoclax-Based Therapy in Two AML Patients with FLT3-ITD Mutation Unresponsive to Venetoclax Plus Azacitidine

Zhang LS, Wang J, Xu MZ, Wu TM, Huang SM, Cao HY, Sun AN, Liu SB, Xue SL

OncoTargets and Therapy 2022, 15:159-164

Published Date: 18 February 2022

Treatment Patterns and Outcomes Among Elderly Glioblastoma Patients in Riyadh, Saudi Arabia

Marie A, Maklad A, AlTwairgi A, Aly M, Elyamany A, AlShaqweer W, Senosy M, Balbaid A

OncoTargets and Therapy 2022, 15:135-144

Published Date: 2 February 2022

lncRNA HAND2-AS1 Regulates Prostate Cancer Cell Growth Through Targeting the miR-106a-5p/RBM24 Axis [Retraction]

Wei P, Yang J, Zhang D, Cui M, Li L

OncoTargets and Therapy 2022, 15:133-134

Published Date: 28 January 2022

Knockdown of Long Noncoding RNA 00152 (LINC00152) Inhibits Human Retinoblastoma Progression [Retraction]

Li S, Wen D, Che S, Cui Z, Sun Y, Ren H, Hao J

OncoTargets and Therapy 2022, 15:119-120

Published Date: 26 January 2022

Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia

De Santis S, Monaldi C, Mancini M, Bruno S, Cavo M, Soverini S

OncoTargets and Therapy 2022, 15:103-116

Published Date: 25 January 2022

Stichoposide C Exerts Anticancer Effects on Ovarian Cancer by Inducing Autophagy via Inhibiting AKT/mTOR Pathway

Liu F, Tang L, Tao M, Cui C, He D, Li L, Liao Y, Gao Y, He J, Sun F, Lin H, Li H

OncoTargets and Therapy 2022, 15:87-101

Published Date: 21 January 2022

Prognostic Implications of Six Altered Genes in Asian Non-Surgical Esophageal Carcinoma Patients Treated with Chemoradiotherapy

Feng A, Yang N, Yu R, Liu J, Pang J, Wu X, Shao Y, Yang Z, Dai H

OncoTargets and Therapy 2022, 15:41-51

Published Date: 13 January 2022

Secondary Nasopharyngeal Mixed Adenoneuroendocrine Carcinoma After Radical Radiotherapy for Nasopharyngeal Carcinoma: A Rare Case and Literature Review [Corrigendum]

Huang D, Huang C, Wang H, He L, Zhang J, Zhong X, Guo Z, Yuan Y, Zhang W

OncoTargets and Therapy 2022, 15:21-22

Published Date: 7 January 2022